ImmunityBio
IBRX
#1926
Rank
NZ$18.74 B
Marketcap
NZ$17.69
Share price
1.64%
Change (1 day)
304.30%
Change (1 year)

Market capitalization of ImmunityBio (IBRX)

Market cap: NZ$18.74 Billion

As of October 2026 ImmunityBio has a market cap of NZ$18.74 Billion. This makes ImmunityBio the world's 1926th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ImmunityBio from 2021 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$18.74 B415.03%
2025NZ$3.63 B1.12%
2024NZ$3.59 B-32.09%
2023NZ$5.30 B65.81%
2022NZ$3.19 B-9.72%
2021NZ$3.54 B

End of Day market cap according to different sources

On Oct 7th, 2026 the market cap of ImmunityBio was reported to be:

NZ$18.44 Billion
by Nasdaq info icon info icon
NZ$18.44 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
NZ$2.22 B-88.13%๐Ÿ‡บ๐Ÿ‡ธ USA